PORTSMOUTH, N.H., April 26, 2013 /PRNewswire/ -- Michaeline Daboul, President & CEO of MMIS, Inc., announced the global integration of MediSpend® at CBI's 3rd Global Transparency Reporting Congress in Brussels, Belgium. The integration of these industry-leading products provides global Life Science companies with a unified end-to-end solution to track and manage travel and expenses, manage physician relationships, and ensure regulatory compliance with the Physician Payments Sunshine Act set forth at Section 6002 of the Patient Protection and Affordable Care Act, as well as European Regulations and industry Codes of Conduct.
MobileXpense is a recognized global leader in Travel and Expense Management solutions, supporting customers in over 60 countries and 20 languages worldwide. In order to meet the compliance requirements of Life Science companies, MobileXpense has developed a set of specific functions to enable employees to capture and control spend data and physician information in accordance with specific regulatory requirements while seamlessly integrating with the MediSpend® platform.
"Governments around the world understand the important role transparency plays in protecting patients and eliminating fraud and waste in public health systems. That's why we've seen such a rapid increase in transparency globally," Ms. Daboul stated. "As more countries join the United States to increase transparency between healthcare providers and industry, it is critical for Life Science companies to develop business processes and systems to satisfy compliance requirements across their worldwide operating entities. We've selected MobileXpense as our 'global expense' partner due to the flexibility, ease of configuration and use of their SaaS expense solution; as well as their capacity to support a tax compliant solution in all their markets. The integration of MediSpend® will make the aggregation, tracking, and reporting of health care provider and health care organization relationships easy, efficient, and affordable for companies with global operations," said Daboul.
The United States is a prime example of the global push toward increased health care data transparency. Regulations in the US require pharmaceutical and medical device manufacturers to aggregate and report certain payments and transfers of value over $10 made to physicians and teaching hospitals. Manufacturers must begin collecting data on August 1, 2013 and report the data to the Centers for Medicaid and Medicare Services (CMS) on or before March 31, 2014 and each year thereafter. CMS will make this data available to the public via a searchable website on September 30, 2014 (and on June 30th each subsequent year).
MMIS, Inc. is a global technology company with a suite of proprietary software products and workflows to help its customers ensure regulatory compliance with domestic and international laws governing transparency disclosure and anti-corruption to include the US Sunshine Act, Foreign Corrupt Practices Act, Anti Kick-back statute as well as similar foreign laws and industry codes of conduct. MMIS, Inc. products and services enable pharmaceutical and medical device manufacturers to maintain compliance through the aggregation, analysis and management of data, which is processed through proprietary rules engines and algorithms. Additionally, MMIS, Inc. is the only company to provide an industry wide, free, cloud-based platform for physicians and hospitals to communicate with pharmaceutical and medical device companies. The Physicians Professional Network®, provides a secure, private communication portal that enables physicians to work closely with pharmaceutical and medical device companies to manage and exchange data related to transparency reporting.
Since the introduction of the MediSpend® family of products, MMIS, Inc. has quickly established a global customer base of over 40 leading healthcare organizations and is the leading provider of aggregate spend, proactive notification and dispute resolution solutions for the medical device sector.
About MMIS Inc.
MMIS, Inc. is a global technology company that develops secure communication solutions for Fortune 500 companies. For over a decade, MMIS, Inc. has deployed proprietary open collaboration technologies that enable its clients to drive greater productivity by managing and exchanging data, ideas, opinions, and intellectual capital in an ultra-secure environment.
Developed and marketed by MMIS, Inc., MediSpend® and the MediSpend® Notification and Dispute Resolution solutions are secure hosted platforms sold as software-as-a-service (SaaS) to meet the needs of industry, academic institutions and physicians. Developed by attorneys and IT specialists with over a dozen years of experience in healthcare compliance, the MediSpend® Family of Products represent the first end-to-end compliance solutions designed specifically to help pharmaceutical and medical device companies track and report HCP and HCO spend while simultaneously managing physician relationships. MediSpend® is a customizable, comprehensive, compliance platform to enable life science companies to comply with US and international transparency reporting laws.
MobileXpense offers a fully integrated, web-based travel and expense management solution, compliant with all legal and fiscal requirements, accounting and VAT rules, and this in every country in which the company operates. A pragmatic approach guarantees an easy implementation very quickly, and with no fuss. On average, a return on investment is achieved in just five months. With customers in over 60 countries, MobileXpense demonstrates global capability, while being proud of the unique local adaptability.
SOURCE MMIS, Inc.